glp 1 and stomach paralysis is the rare Ozempic risk worth watching For patients taking GLP-1 receptor
Description
, HecksherSoerensen, J
Both substances influence glucose metabolism, warranting medical consultation before combined use
10.1111/dom.13258 77
[DOI] [PubMed] [Google Scholar] 110.Lien F., Berthier A., Bouchaert E., Gheeraert C., Alexandre J., Porez G., Prawitt J., Dehondt H., Ploton M., Colin S., et al
#ClinicalResearch #Oncology #RegulatoryAffairs #ClinicalTrials #CARTtherapy #RegenerativeMedicine #MedicalCompliance #GxP #HealthcareRisk #MedicalWriting #LifeSciences To view or add a comment, sign in From laboratory discoveries to life-changing therapies, innovation becomes meaningful when it reaches patients
